Medical Technology Made in Berlin-Brandenburg
Berlin, Feb. 17, 2026 – Berlin-Brandenburg stands at the forefront of Europe’s medtech landscape and has sustained remarkable growth for many years. Around 380 companies employing nearly 17,000 people generate annual revenues of €1.5 billion. The ecosystem is shaped by small and mid-sized enterprises – many of them global market leaders in their respective fields. Companies in the region draw on world-class academic research and work side by side with leading scientific institutions and top-tier clinics. Key focus areas include telemedicine and digital health, imaging, oncology, cardiology, minimally invasive procedures, and organ support and replacement systems – fields in which numerous high-performing, innovation-driven companies are active.
Innovation driving markets
Medical technology today is high tech in the truest sense. ICompanies leverage the latest advances in artificial intelligence, robotics, immersive technologies, quantum technologies, sensor systems and additive manufacturing to elevate diagnostics, therapy and patient care to entirely new levels. Globally successful products from the region include ventricular assist devices in the form of external heart pumps from Berlin Heart, pacemakers from Biotronik and stents from B. Braun. In minimally invasive medicine, Berlin-based companies such as World of Medicine, MGB Endoskopische Geräte Berlin and XION have established a strong international presence with endoscopes, insufflators and camera systems. The orthopaedics segment is represented by companies including aap Implantate, Merete Medical, OHST and ZIMMER Biomet Deutschland . In nuclear medicine, innovative products are developed both in research institutions and at companies such as nanoPET Pharma and global market leader Eckert & Ziegler Strahlen- und Medizintechnik.
Turning research into competitive products
Medtech in Berlin-Brandenburg excels at turning research into real-world solutions. A seamless transfer of technology – powered by close collaboration between hospitals, research institutions and industry – ensures that innovations move quickly from the lab to competitive products and reach patients at an early stage. Through strong networking across the entire value chain, the region has achieved some of the highest growth rates in Germany’s medtech sector
With more than 150 hospitals, the German capital region offers an exceptionally robust healthcare infrastructure. Strong partners for research, development and clinical validation make Berlin and Brandenburg an ideal location for developing medical technologies with broad real-world applications.
In addition to Charité – Universitätsmedizin Berlin, the capital region is home to more than 40 top-tier scientific institutions, including the Berlin Institute of Health (BIH), the German Heart Center Berlin, the Physikalisch-Technische Bundesanstalt (PTB), the Fraunhofer Institute for Biomedical Engineering IBMT, as well as numerous institutes within the Fraunhofer, Helmholtz, Leibniz and Max Planck networks across Berlin and Brandenburg.
Further insights and the full analysis of the capital region’s medtech sector are available here:
